Search
for

    Sort by

    Research 211–240 of 1000+

    1. 3α-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats Frontiers in Aging Neuroscience · 2010 · 63 citations
    2. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor BMC Endocrine Disorders · 2014 · 62 citations
    3. Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer Research Square (Research Square) · 2021
    4. En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio Evidencia · 2021
    5. Preventable effect of L-threonate, an ascorbate metabolite, on androgen-driven balding via repression of dihydrotestosteroneinduced dickkopf-1 expression in human hair dermal papilla cells BMB Reports · 2010 · 31 citations
    6. Preventable effect of L-threonate, an ascorbate metabolite, on androgen-driven balding via repression of dihydrotestosteroneinduced dickkopf-1 expression in human hair dermal papilla cells BMB Reports · 2010 · 2 citations
    7. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology and Metabolism · 2013 · 1265 citations
    8. Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjects Journal of The American Academy of Dermatology · 1993 · 222 citations
    9. MELATONIN Clinical endocrinology · 1988 · 220 citations
    10. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study Journal of Clinical Medicine · 2022 · 202 citations
    11. The psychological effects of androgenetic alopecia in men Journal of The American Academy of Dermatology · 1992 · 192 citations
    12. A New Look at the 5?-Reductase Inhibitor Finasteride Cns Drug Reviews · 2006 · 137 citations
    13. Alopecia areata and health-related quality of life: a systematic review and meta-analysis British Journal of Dermatology · 2016 · 128 citations
    14. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up British Journal of Dermatology · 2017 · 105 citations
    15. Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study PLOS ONE · 2014 · 101 citations
    16. Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review Dermatology and Therapy · 2021 · 67 citations
    17. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride Journal of Dermatological Treatment · 2013 · 66 citations
    18. Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma The Journal of Steroid Biochemistry and Molecular Biology · 2014 · 61 citations
    19. Psychosocial dimensions of SLE: implications for the health care team Journal of Multidisciplinary Healthcare · 2011 · 54 citations
    20. Adverse Reactions to Oral Retinoids An Update Drug Safety · 1993 · 53 citations
    21. Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome JAMA dermatology · 2016 · 52 citations
    22. Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss The Journal of Clinical Endocrinology and Metabolism · 2016 · 50 citations
    23. ‘The psychosocial burden of alopecia areata and androgenetica’: a cross‐sectional multicentre study among dermatological out‐patients in 13 European countries Journal of the European Academy of Dermatology and Venereology · 2019 · 46 citations
    24. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia International Journal of Dermatology · 2003 · 46 citations
    25. Psychological features of androgenetic alopecia<sup>1</sup> Journal of the European Academy of Dermatology and Venereology · 2002 · 46 citations
    26. Mood disorders and quality of life in polycystic ovary syndrome Gynecological Endocrinology · 2015 · 42 citations
    27. Health Status, Coping Strategies, and Alexithymia in Subjects with Androgenetic Alopecia American Journal of Clinical Dermatology · 2013 · 40 citations
    28. The Medical and Psychosocial Associations of Alopecia: Recognizing Hair Loss as More Than a Cosmetic Concern American Journal of Clinical Dermatology · 2018 · 36 citations
    29. Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database The Journal of Dermatology · 2022 · 35 citations
    30. Polycystic Ovarian Syndrome: Long-Term Health Consequences Seminars in Reproductive Medicine · 2017 · 34 citations